Samik Pharmaceutical Company LTD. (014950)
Stock listed on Korea Exchange (KOSDAQ market) (KOSDAQ) · 의약품 제조업 · prices in KRW
Price
6,760 KRW−400.00 (−5.59%)Close on (end-of-day, stored)
Key statistics · as of Nov 3, 2026
- 52-week range
- 3,705.00 – 25,050.00
- Market cap
- 62.3B KRW
- P/E
- —
- P/B
- 0.9
- EV/EBITDA
- 18.3
- Dividend yield
- 0.59%
- 1-year return
- —
- 3-month return
- +59.2%
- Volatility (1y)
- 128.0%
- Max drawdown (1y)
- −81.9%
- Beta (1y)
- 0.67
- RSI (14)
- 42
- Revenue growth
- —
- ROE
- −2.1%
- ROIC
- 2.7%
- Debt / equity
- 0.04
Ratios are calculated by AlphaScope from stored prices and reported financial statements; see the methodology. Blank values mean the data is not available.
Financial statements · annual · KRW
| Fiscal year ending | Dec 31, 2025 | Dec 31, 2024 |
|---|---|---|
| Revenue | 60B | — |
| Gross profit | 42.4B | — |
| Operating income | 3.3B | 3.7B |
| Net income | -754.9M | 3.5B |
| EPS (diluted) | −99.00 | — |
| Total assets | 85.2B | — |
| Total liabilities | 16.2B | — |
| Shareholders’ equity | 69B | 52B |
| Operating cash flow | 2.1B | — |
| Free cash flow | -1.4B | — |
Source: Yahoo Finance fundamentals (standardised, unofficial). Full income statement, balance sheet and cash flow, quarterly and trailing-twelve-month views are in the app.
Peers · 의약품 제조업
| Company | Market cap | 1-year return |
|---|---|---|
| Yuhan Corporation (000100) | 5.7T | −34.6% |
| Hanmi Pharm. Co., Ltd. (128940) | 5.4T | +23.4% |
| Sam Chun Dang Pharm. Co., Ltd (000250) | 4.3T | −10.7% |
| Hanall Biopharma Co., Ltd. (009420) | 1.9T | +7.8% |
| Celltrion Pharm, Inc. (068760) | 1.6T | −35.5% |
| ST Pharm Co.,Ltd. (237690) | 1.5T | −24.8% |
| GC Biopharma Corp. (006280) | 1.5T | +0.6% |
| Oscotec Inc. (039200) | 1.4T | −9.2% |
014950 news
No stored headlines.